- Home
- LAC vs IMTX Comparison
LAC vs IMTX Comparison
Compare LAC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAC | IMTX |
|---|---|---|
| Founded | 2023 | N/A |
| Country | Canada | Germany |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LAC | IMTX |
|---|---|---|
| Price | $6.44 | $9.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $6.17 | ★ $19.25 |
| AVG Volume (30 Days) | ★ 16.7M | 359.4K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,445,031.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $3.30 |
| 52 Week High | $10.52 | $12.41 |
Technical Indicators
Market Signals| Indicator | LAC | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.23 | 50.96 |
| Support Level | $5.46 | $9.55 |
| Resistance Level | $6.16 | $10.36 |
| Average True Range (ATR) | 0.42 | 0.54 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 86.74 | 63.52 |
Price Performance
Historical ComparisonAbout LAC Lithium Americas Corp.
Lithium Americas is a pure-play lithium producer. Following a deal with the US government, the firm will own 59% of one resource, Thacker Pass, which is located in northwest Nevada, with automaker General Motors owning 36% and the US government owning 5%. Thacker Pass is under construction and expected to begin production in 2028. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.